Add to ORKGHospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drug
BACKGROUND: Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylure...
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achievin...
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achievin...
Aims/hypothesis Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predo...
Aims/hypothesis Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predo...
Background: The results of clinical trials have suggested that the thiazolidinedione antidiabetic ag...
OBJECTIVE - The purpose of this study was to examine possible factors associated with the increased ...
Background: Clinical trials and meta-analyses have found that rosiglitazone maleate, a thiazolidined...
*<p>8 persons missing data on region of residence excluded.</p><p>HR = Hazard ratio.</p>†<p>Age, cor...
OBJECTIVE: To compare the risk of acute myocardial infarction, heart failure, and death in patients ...
none6noAltre info: DOI dell'intero fascicolo: 10.1002/pds.2019Background: Thiazolidinediones (TZDs) ...
Purpose of Review: Diabetes mellitus (DM) is associated with increased fracture risk. The aim of thi...
Context: Pioglitazone reduces cardiovascular risk in nondiabetic patients after an ischemic stroke o...
We report the risks of a comprehensive range of disease and drug categories on hip fracture occurren...
We report the risks of a comprehensive range of disease and drug categories on hip fracture occurren...
BACKGROUND: Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylure...
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achievin...
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achievin...
Aims/hypothesis Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predo...
Aims/hypothesis Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predo...
Background: The results of clinical trials have suggested that the thiazolidinedione antidiabetic ag...
OBJECTIVE - The purpose of this study was to examine possible factors associated with the increased ...
Background: Clinical trials and meta-analyses have found that rosiglitazone maleate, a thiazolidined...
*<p>8 persons missing data on region of residence excluded.</p><p>HR = Hazard ratio.</p>†<p>Age, cor...
OBJECTIVE: To compare the risk of acute myocardial infarction, heart failure, and death in patients ...
none6noAltre info: DOI dell'intero fascicolo: 10.1002/pds.2019Background: Thiazolidinediones (TZDs) ...
Purpose of Review: Diabetes mellitus (DM) is associated with increased fracture risk. The aim of thi...
Context: Pioglitazone reduces cardiovascular risk in nondiabetic patients after an ischemic stroke o...
We report the risks of a comprehensive range of disease and drug categories on hip fracture occurren...
We report the risks of a comprehensive range of disease and drug categories on hip fracture occurren...
BACKGROUND: Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylure...
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achievin...
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achievin...